1. CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin
   Sirichat Kaowinn et al, 2019, International Journal of Oncology CrossRef
2. One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment
   Xing Huang et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
3. Nek2A/SuFu feedback loop regulates Gli-mediated Hedgehog signaling pathway
   Fen Zhou et al, 2017, International Journal of Oncology CrossRef
4. Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities
   Jian-Bei Xi et al, 2017, European Journal of Medicinal Chemistry CrossRef
5. MicroRNA‐128 promotes apoptosis in lung cancer by directly targeting NIMA‐related kinase 2
   Dejian Zhao et al, 2017, Thoracic Cancer CrossRef
6. Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis
   Huanqing Liu et al, 2021, BioMed Research International CrossRef
7. Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
   Dan-ming Wei et al, 2018, Respiratory Research CrossRef
8. Prognostic significance of NEK2 in human solid tumors: a systematic review and meta-analysis
   Xichen Wang et al, 2019, Bioscience Reports CrossRef
9. Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis
   Beatriz Andrea Otálora-Otálora et al, 2022, Biology CrossRef
10. In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC)
    Ambritha Balasundaram et al, 2023, Computers in Biology and Medicine CrossRef
11. Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development
    Dibyendu Dana et al, 2022, Molecules CrossRef
12. Evaluating the Expression and Prognostic Value of Genes Encoding Microtubule-Associated Proteins in Lung Cancer
    Natsaranyatron Singharajkomron et al, 2022, International Journal of Molecular Sciences CrossRef
13. Deguelin inhibits epithelial‐to‐mesenchymal transition and metastasis of human non‐small cell lung cancer cells by regulating NIMA‐related kinase 2
    Dejian Zhao et al, 2017, Thoracic Cancer CrossRef
14. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation
    Sailan Wen et al, 2016, Oncology Reports CrossRef
15. Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2
    Byung-Kwon Choi et al, 2018, Proceedings of the National Academy of Sciences CrossRef
16. Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers
    Yainyrette Rivera-Rivera et al, 2022, Cell Division CrossRef
17. CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle
    Hao-Yu Zhou et al, 2024, Oncology Letters CrossRef
18. Behavior of intracellular lipid droplets during cell division in HuH7 hepatoma cells
    Tomohiko Makiyama et al, 2023, Experimental Cell Research CrossRef
19. Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options
    Alicja Czubaty et al, 2017, The International Journal of Biochemistry & Cell Biology CrossRef
20. Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2
    Jia Wang et al, 2017, Journal of Clinical Investigation CrossRef
21. Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies
    Song Wen et al, 2015, BMC Cancer CrossRef
22. Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma
    Huajie Liu et al, 2017, Journal of Neuro-Oncology CrossRef
23. Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer
    Wen-Liang Gao et al, 2022, Frontiers in Genetics CrossRef